Author:
Helfer Brooke M.,Ponomarev Vladimir,Patrick P. Stephen,Blower Philip J.,Feitel Alexandra,Fruhwirth Gilbert O.,Jackman Shawna,Pereira Mouriès Lucilia,Park Margriet V.D.Z.,Srinivas Mangala,Stuckey Daniel J.,Thu Mya S.,van den Hoorn Tineke,Herberts Carla A.,Shingleton William D.
Funder
Health and Environmental Sciences Institute
European Commission
Horizon 2020
Subject
Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy
Reference187 articles.
1. European Medicines Agency. Advanced therapy medicinal products: overview. https://www.ema.europa.eu/en/human-regulatory/overview/advanced-therapy-medicinal-products-overview; 2020 [accessed 20 March 2020].
2. Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance;Boyiadzis;J Immunother Cancer,2018
3. CAR T cell immunotherapy for human cancer;June;Science,2018
4. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia;Maude;N Engl J Med,2018
5. Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors;Kochenderfer;Nat Rev Clin Oncol,2013
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献